Engineering Tomorrow’s Neurological Therapies
At Keystone Neurogenics, we harness cutting-edge gene therapy and artificial intelligence to develop transformative treatments that improve lives impacted by neurodegenerative diseases.
Transforming Neurological Care with Innovation
Our proprietary AI integrates with advanced gene-editing technologies to precisely identify and treat patients, offering hope and meaningful therapeutic progress for neurological disorders.
Why Choose Keystone Neurogenics
Leading innovation at the intersection of gene-editing and AI to deliver impactful neurological therapies.
Proprietary AI Integration
Advanced artificial intelligence pinpoints optimal patients for precise and effective treatment outcomes.
Cutting-Edge Gene Therapy
Utilizing next-generation gene-editing technologies to develop therapies that delay onset and treat devastating neurodegenerative diseases.
Experienced Leadership
Guided by a world-class team committed to scientific excellence and patient-focused innovation.
Patient-Centered Progress
Dedicated to bringing hope and clarity through treatments that improve quality of life for patients and families.
Innovative Gene-Editing Powered by AI Precision
Precision Therapies for Neurodegenerative Diseases
Contact us
Telephone: +1 (215) 429 0994
E-mail: info@keystoneneurogenics.com
Address: 330 Linden Ave, Doylestown, PA 18901